Cindy Schwartz MD MPH

PubMed

• PET Response and Outcome in Low-Risk Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1.
  Lianna J Marks, Yue Wu, Kathleen M McCarten, Lindsay A Renfro, Qinglin Pei
  Pediatric Blood & Cancer. 2025-05-01
• 1 citations
  Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial.
  Bradford S Hoppe, Sarah A Milgrom, Lindsay A Renfro, Yue Wu, Cindy L Schwartz
  JAMA Oncology. 2025-03-01
• 1 citations
  Long-term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS).
  Kerri Becktell, Yan Chen, Yutaka Yasui, Rachel Phelan, Gregory T Armstrong
  Pediatric Blood & Cancer. 2024-10-01

Journal Articles

• Pericardial Effusion in Hodgkin Lymphoma: A Report from the Children's Oncology Group AHOD0031  
  Lianna J Marks, Debra L Friedman, Cindy L Schwartz, Kathleen McCarten, Blood
• Exercise and Fatigue in Adolescent and Young Adult Survivors of Hodgkin Lymphoma: A Report from the Children's Oncology Group  
  Macpherson CF, Hooke MC, Friedman DL, Campbell K, Withycombe J, Kelly K, Meza J, J Adolesc Young Adult Oncol, 1/1/2015
• Late Mortality After Dexrazoxane Treatment: A Report From the Children's Oncology Group  
  Chow EJ, Asselin BL, Doody DR, Leisenring WM, Aggarwal S, Baker KS, Bhatia S, Constine LS, Freyer DR, Lipshultz SE, Armenian SH, J Clin Oncol, 1/1/2015
• A phase 2 study of bortezomib in combination with ifosfamide/vinorelbine in paediatric patients and young adults with refractory/recurrent Hodgkin lymphoma: a Children...  
  Horton TM, Drachtman RA, Chen L, Cole PD, McCarten K, Voss S, Guillerman RP, Buxton A, Howard SC, Hogan SM, Sheehan AM, López-Terrada D, Mrazek MD, Agrawal N, Wu MF, L..., Br J Haematol, 1/1/2015
• Patterns of Relapse From a Phase III Study of Response-Based Therapy for Intermediate-Risk Hodgkin Lymphoma (AHOD0031): A Report From the Children's Oncology Group  
  Dharmarajan KV, Friedman DL, Chen L, FitzGerald TJ, McCarten KM, Kessel SK, Iandoli M, Constine LS, Wolden SL, Int J Radiat Oncol Biol Phys, 1/1/2015
• Survivorship  
  Harrison DJ, Schwartz C, J Surg Oncol, 1/1/2015
• Ifosfamide and vinorelbine is an effective reinduction regimen in children with refractory/relapsed Hodgkin lymphoma, AHOD00P1: A children's oncology group report  
  Trippett TM, Guillerman RP, Gamis AS, Gardner S, Hogan S, London WB, Chen L, de Alarcon P, Pediatr Blood Cancer, 1/1/2015
• Dose-Intensive Response-Based Chemotherapy and Radiation Therapy for Children and Adolescents With Newly Diagnosed Intermediate-Risk Hodgkin Lymphoma: A Report From th...  
  Friedman DL, Chen L, Wolden S, Buxton A, McCarten K, FitzGerald TJ, Kessel S, De Alarcon PA, Chen AR, Kobrinsky N, Ehrlich P, Hutchison RE, Constine LS, J Clin Oncol, 1/1/2014
• Response-dependent and reduced treatment in lower risk Hodgkin lymphoma in children and adolescents, results of P9426: a report from the Children's Oncology Group  
  Tebbi CK, Mendenhall NP, London WB, Williams JL, Hutchison RE, Fitzgerald TJ, de Alarcón PA, Chauvenet A, Pediatr Blood Cancer, 1/1/2012
• Outcome for adolescent and young adult patients with osteosarcoma: a report from the Children's Oncology Group  
  Janeway KA, Barkauskas DA, Krailo MD, Meyers PA, Ebb DH, Seibel NL, Grier HE, Gorlick R, Marina N, Cancer, 1/1/2012
• The low incidence of secondary acute myelogenous leukemia in children and adolescents treated with dexrazoxane for acute lymphoblastic leukemia: a report from the Dana...  
  Vrooman LM, Neuberg DS, Stevenson KE, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Larsen EC, Laverdière C, Michon B, Schorin M, Cohen HJ, Lipshultz SE, Silver..., Eur J Cancer, 1/1/2011
• Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma  
  Loeb DM, Hobbs RF, Okoli A, Chen AR, Cho S, Srinivasan S, Sgouros G, Shokek O, Wharam MD, Scott T, Cancer, 1/1/2010
• Early [¹ F]fluorodeoxyglucose positron emission tomography-based response evaluation after treatment with gemcitabine and vinorelbine for refractory Hodgkin disease: a...  
  Cole PD, McCarten KM, Drachtman RA, Alarcon Pd, Chen L, Trippett TM, Pediatr Hematol Oncol, 1/1/2010
• Quality of radiotherapy reporting in randomized controlled trials of Hodgkin's lymphoma and non-Hodgkin's lymphoma: in regard to Bekelman and Yahalom (Int J Radiat Onc...  
  Fitzgerald TJ, Bishop-Jodoin M, Cicchetti MG, Hanusik R, Kessel S, Laurie F, McCarten KM, Moni J, Pieters RS, Rosen N, Ulin K, Urie M, Chauvenet AR, Constine LS, Deye ..., Int J Radiat Oncol Biol Phys, 1/1/2010
• Intravenous PEG-asparaginase during remission induction in children and adolescents with newly diagnosed acute lymphoblastic leukemia  
  Silverman LB, Supko JG, Stevenson KE, Woodward C, Vrooman LM, Neuberg DS, Asselin BL, Athale UH, Clavell L, Cole PD, Kelly KM, Laverdière C, Michon B, Schorin M, O'Bri..., Blood, 1/1/2010
• A risk-adapted, response-based approach using ABVE-PC for children and adolescents with intermediate- and high-risk Hodgkin lymphoma: the results of P9425  
  Constine LS, Villaluna D, London WB, Hutchison RE, Sposto R, Lipshultz SE, Turner CS, deAlarcon PA, Chauvenet A, Blood, 1/1/2009
• Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000)  
  Silverman LB, Stevenson KE, O'Brien JE, Asselin BL, Barr RD, Clavell L, Cole PD, Kelly KM, Laverdiere C, Michon B, Schorin MA, O'Holleran EW, Neuberg DS, Cohen HJ, Sal..., Leukemia, 1/1/2009
• Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma  
  Loeb DM, Garrett-Mayer E, Hobbs RF, Prideaux AR, Sgouros G, Shokek O, Wharam MD, Scott T, Cancer, 1/1/2009
• Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report  
  Cole PD, Drachtman RA, de Alarcon PA, Chen L, Trippett TM, J Clin Oncol, 1/1/2009
• Unilateral and bilateral breast cancer in women surviving pediatric Hodgkin's disease  
  Basu SK, Fisher SG, Hudson MM, Tarbell N, Muhs A, Marcus KJ, Mendenhall N, Mauch P, Kun LE, Constine LS, Int J Radiat Oncol Biol Phys, 1/1/2008
• Subsequent malignancies in children treated for Hodgkin's disease: associations with gender and radiation dose  
  Constine LS, Tarbell N, Hudson MM, Fisher SG, Muhs AG, Basu SK, Kun LE, Ng A, Mauch P, Sandhu A, Culakova E, Lyman G, Mendenhall N, Int J Radiat Oncol Biol Phys, 1/1/2008
• American Society of Clinical Oncology Clinical Evidence Review on the Ongoing Care of Adult Cancer Survivors: Cardiac and Pulmonary Late Effects  
  Carver J, Shapiro C, Ng A, Jacobs L, et al., J Clin Oncol, 1/1/2007
• Population pharmacokinetics of micafungin in pediatric patients and implications for antifungal dosing  
  Hope WW, Seibel NL, Arrieta A, Flynn P, Shad A, Albano E, Keirns JJ, Buell DN, Gumbo T, Drusano GL, Walsh TJ, Antimicrob Agents Chemother, 1/1/2007
• Curing Hodgkin Disease: Too much of a good thing Current Controversies in Oncology  
  Schwartz CL, ASCO News and Forum, 1/1/2007
• Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents  
  Walsh TJ, Adamson PC, Seibel NL, Flynn PM, Neely MN, Shad A, Kaplan SL, Roden MM, Stone JA, Miller A, Bradshaw SK, Li SX, Sable CA, Kartsonis NA, Antimicrob Agents Chemother, 1/1/2005
• Join now to see all

Books/Book Chapters

• Evidence Based Pediatric Oncology 
  Chapter: Hodgkin Lymphoma (Commentary) 
  Page 105 - 108Schwartz CLEditors: Pinkerton R, Shankar A, Matthay KK.Wiley-BlackwellEdition 3rd,2013
• Educating the Child with Cancer: A Guide for Parents & Teachers 
  Chapter: Physical Activity 
  Ruble K, Schwartz CEditors: Keen N.American Childhood Cancer Organization2011
• ASCO Educational Book 
  Chapter: Early Response-based Therapy for Children with Hodgkin Lymphoma: A Surrogate for Using Biology to Effect Cure and Minimize Toxicity 
  Schwartz CL2010
• Textbook of Pediatric Care 
  Chapter: Cancers in Childhood 
  Page 1873 - 1902Hinkle AS, Schwartz CLEditors: McInerny TK.American Academy of Pediatrics, Elk Grove Village, IL2009
• Pediatric Lymphomas 
  Chapter: Treatment of Pediatric Hodgkin Lymphoma 
  Page 35 - 66Hudson MM, Constine LSEditors: Weinstein HJ, Hudson MM, Link MP.Springer2007
• Survivors of Childhood and Adolescent Cancer – A Multidisciplinary Approach 
  Hobbie WL, Constine LC, Ruccione KSEditors: Schwartz CL, Hobbie WL, Constine LC, Ruccione KS.Springer-Verlag & Co., Heidelberg2005
• Survivors of Childhood Cancer - Assessment and Management 
  Chapter: Algorithms of Late Effects by Disease 
  Page 7 - 20Hobbie WL, Constine LC, Ruccione KSEditors: Schwartz CL, Hobbie WL, Constine LC, Ruccione KS.Mosby Yearbook, Missouri1994
• Survivors of Childhood Cancer - Assessment and Management 
  Chapter: Cardiovascular Effects of Therapy 
  Page 159 - 176Truesdell S, Clark EEditors: Schwartz CL, Hobbie WL, Constine LC, Ruccione KS.Mosby Yearbook, Inc., Missouri1994
• Survivors of Childhood Cancer - Assessment and Management 
  Hobbie WL, Constine LC, Ruccione KSEditors: Schwartz CL, Hobbie WL, Constine LC, Ruccione KS.Mosby Yearbook, Inc, Missouri1994
• Clinical Oncology, A Multidisciplinary Approach 
  Chapter: Pediatric solid tumors 
  Page 251 - 298Constine LC, Putnam TC, Cohen HJSaunders WBEdition 7th,1993
• Cardiac toxicity cardiomyopathy after Cancer Therapy 
  Chapter: The Use of the QTc in screening for anthracycline related cardiotoxicity 
  Page 103 - 108Truesdell SA, Clark EBEditors: Bricker GT, D'Angio GJ, Green DM.John Wiley and Sons, New York1993
• Pediatric Primary Care 
  Chapter: Cancers in Childhood 
  Page 1157 - 1179Schwartz CLEditors: Hoekelman R.Mosby, Mosby1992
• Merck Manual 
  Chapter: Retinoblastoma 
  Page 2205 - 2206Schwartz CLEditors: Berkow R. Merck.Sharp & Dohme Research Laboratories, Rahway, NJEdition 16th,1992
• Hematology: Basic Principles and Practice 
  Chapter: Myelodysplastic and myeloproliferative disorders in children 
  Page 889 - 896Schwartz CLEditors: Hoffman R, Benz EJ, Shattil S, Furie B, Cohen HJ.Churchill Livingstone, New York1991
• Principles and Practice of Pediatric Oncology 
  Chapter: Myeloproliferative and myelodysplastic syndromes 
  Page 397 - 413Schwartz CL, Cohen HJEditors: Pizzo PA, Poplack DG.JB Lippincott Company, Philadelphia, PA1989
• Join now to see all

Abstracts/Posters

• Phase III Study of Response Adapted Therapy for the Treatment of children with Newly Diagnosed Very HIgh Risk Hodgkin Lymphoma (Atages IIIB/IVB) (AHOD0831): A Report ...
  Kelly KM, MD, Cole PD, Chen L, Robrets KB, Hodgson DC, McCarten K, Steve Y Cho SY, Blood, 1/1/2015
• Prediction of Primary Treatment Outcome Using Gene Expression Profiling of Pre-Treatment Biopsies Obtained from CHhildhood and Adolescent Hodgkin Lympjoma Patients
  Mottok A, Johnston Rl, Chan FC, Scott DW, Friedman DL, Kelly K, Terzah M. Horton TM.Steidl C, Blood, 1/1/2015
• Outcomes in Adolescents and Young Adults (AYA) with Hodgkin Lymphoma (HL) Treat on US Cooperative Group Protocols: An Adult Intergroup (E2496) and Children's Oncology...
  Tara O Henderson, MD, MPH, Susa K Parson, MD, MRP, Kristen Wroblewski, MS, Lu Chen PhD, Fangxin Hong, PhDF, Sonali M. Smith, MD, Jennifer McNeer, MD, MS, Ranjana Advan..., Blood (ASH poster), 1/1/2015
• 18F-FDG (FDG) PET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL), A Preliminary Retrospective Analysis of Chi...
  Appel B, Chen L, Hutchison RE, Hodgson DC, Ehrlich P, Constine LC, Blood (ASH poster), 1/1/2015
• Survivial After Recurrence in Osteosarcoma: A Report from the Chidlren's Oncology Group
  Holly L. Spaker-Perlman; Donald A. Barkauskas; Paul A. meyers; David H. Ebb; John J. Doski; Mark D. Krailo; Richard Gorlick; Katherine A. Janeway, Connective Tissue Oncology Society, 1/1/2015
• Small Cell Osteosarcoma: The MD Anderson Cancer Center Experience
  Hatel Rana Moonat, Wei-Lien Wang, Kenneth R. Hess, Michaelle Moise, Shreyaskumar Patel, Robert S. Benjamin, Valerae O. Lewis, Alexander Lazar, Najat C. Daw, Connective Tissue Oncology Society, 1/1/2015
• Safety, Tolerability, and Feasibility of Alpha Particle Radium-223 Dichloride (223RaCI2) in High Risk Osteosarcoma: Phase I Dose Escalation Trial
  V. Subbiah; P. Anderson; W. Huh; K. hess, V,. Ravi; J.G. Fernandez; A. Lui; N Daw, N, Somaiah; C. Kappadath; G. Ravissini; J. Ludwig; S. Chawla; R.S. Benjamin; S. Pate..., Connective Tissue Oncology Society, 1/1/2015
• Outcomes and Patterns of Failure in Children/Adolexcents with Low Risk Hodgkin Lymphoma (HL) Who are FDG-PET (PET3) Positive After AVPC Therapy
  Sharon M. Castellino, Frank Keller, Stephan Voss, Steve Cho, Louis Constine, John Thomson, cherie Dunphy, Kathleen McCarten LuChen, ISCAYAHL, 1/1/2015
• Barriers to Survivorship Care - CONNECCS
  Hirway P, Ader J, Bradeen HA, Grewal SS, Huang MS, Kadan-Lottick N, Usmani N, Kenney LB, Proceedings ASCO, 1/1/2013
• Treatment of pediatric lymphocyte predominant Hodgkin lymphoma (LPHL): A report from the Children's Oncology Group
  Appel B, Chen L, Hutchison RE, Hodgson DC, Ehrlich P, Constine LC, Proceedings ASCO, 1/1/2013
• Treatment of Pediatric Stage IA Lympocyte-Predominant Hodgkin Lympoma with Sugical Resection Alone: A COG Report
  Appel B, Ehrlich P, Chen L, Hutchison RE, Hodgson DC, Constine LS, Proceedings ASCO, 1/1/2012
• The Effects of Dexrazoxane on Cardiac Funtion and Secondary Malignant Neoplasms in Patients with Osteosarcoma (OS)
  Kopp L, Bernstein ML, Ebb D, Krailo MD, Frier HE, Meyers PA,k Wexler LH, Marina N, Womer R, Janeway KA, Gorlick RG, Lipshultz SE, Proceedings ASCO, 1/1/2012
• HER2 Expression is Not Prognostic in Osteosarcoma
  Gorlick R, Barkauskas D, Krailo M, Piperdi S, Sowers R, Gorlick S, Gill J, Geller D, Randall L, Janeway K, Grier H, Meyers P, Bernstein M, Marina N, CTOS, 1/1/2012
• Albumin: A Predictor of EFS in MC Hodgkin Lymphoma
  Kaplann UJ, Chen L, Hutchison R, Friedman D, SIOP, 1/1/2012
• 18F-FDG (FDG) OET Five-Point Visual and Quantitative SUV-Based Assessment and Prognosis in Pediatric Hodgkin Lymphoma (HL)
  Appel B, Chen L, Hutchison RE, Hodgson DC, Ehrlich P, Constine LC, ASH, 1/1/2012
• Early PET and CT as predictors of outcome in pediatric Hodgkin lymphoma, Society International Pediatric Oncology
  Friedman DL, McCarten K, Wolden S L, Voss S, Constine LS, Chen L, Pediatric Blood Cancer, 1/1/2011
• The Childhood Hodgkin International Prognostic Score (CHIPS) for Predicting Event Free Survival in Pediatric and Adolescent Hodgkin Lymphoma
  Chen L, Constine L, Wolden S, Keller FG, Kelly KM, Friedman DL, Blood, 1/1/2011
• Survival in Adolescents and Young Adults with Hodgkin Lymphoma Treated with Response-Based Chemotherapy on P9425 and P9426 Protocols: A Report From the Children’s Onco...
  Fernandez KS, Chen L, Chauvenet A, deAlarcon PA, Blood, 1/1/2011
• Predictors of Early Response and Event Free Survival in Hodgkin Lymphoma (HL): PET vs CT Imaging
  Friedman DL, McCarten K, Wolden SL, Voss S, Constine LS, Chen L, Proceedings ASCO, 1/1/2011
• Mixed Cellularity Histology Confers Favorable Prognosis in Children and Adolescents with Low Risk Hodgkin Lymphoma (HL)
  Castellino C, keller F, Dunphy C, Nachman J, Constine L, Chen L, 1st International Symposium on Childhood, Asolescent, and Young Adulty Hodgkin Lymphona, 1/1/2011
• Join now to see all